Semnur Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Semnur Pharmaceuticals, Inc. (SMNR) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $451.96 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2025-08-15
- Semnur Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $319.49K, a 912.47% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-03-31 was $132.47K, a 147.49% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-12-31 was $781.16K, a 12354.66% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-09-30 was $24.60K, a 93.96% decline year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $890.83K, a 63.76% decline from fiscal 2023.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $2.46M, a 90.30% increase from fiscal 2022.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $1.29M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $319.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $451.96K 10-Q · filed 2025-08-15 | $1.23M derived: sum of 3 quarters · filed 2025-08-15 | $1.26M derived: sum of 4 quarters · filed 2025-08-15 |
| 2025-03-31 | $132.47K 10-Q · filed 2025-05-16 | $913.62K derived: sum of 2 quarters · filed 2025-05-16 | $938.22K derived: sum of 3 quarters · filed 2025-05-16 | $969.78K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-12-31 | $781.16K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $805.75K derived: sum of 2 quarters · filed 2025-04-02 | $837.31K derived: sum of 3 quarters · filed 2025-08-15 | $890.83K 10-K · filed 2025-04-02 |
| 2024-09-30 | $24.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $56.15K derived: sum of 2 quarters · filed 2025-08-15 | $109.68K 10-Q · filed 2024-11-19 | $115.95K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-06-30 | $31.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $85.08K 10-Q · filed 2025-08-15 | $91.35K derived: sum of 3 quarters · filed 2025-08-15 | $498.46K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | $53.52K 10-Q · filed 2025-05-16 | $59.80K derived: sum of 2 quarters · filed 2025-05-16 | $466.90K derived: sum of 3 quarters · filed 2025-05-16 | $824.29K derived: sum of 4 quarters · filed 2025-05-16 |
| 2023-12-31 | $6.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $413.38K derived: sum of 2 quarters · filed 2025-04-02 | $770.76K derived: sum of 3 quarters · filed 2025-04-02 | $2.46M 10-K · filed 2025-04-02 |
| 2023-09-30 | $407.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $764.49K derived: sum of 2 quarters · filed 2024-11-19 | $2.45M 10-Q · filed 2024-11-19 | $3.65M derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | $357.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $2.04M 10-Q · filed 2024-08-19 | $3.25M derived: sum of 3 quarters · filed 2024-08-19 | $3.26M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $1.69M 10-Q · filed 2024-05-22 | $2.89M derived: sum of 2 quarters · filed 2024-05-22 | $2.90M derived: sum of 3 quarters · filed 2024-05-22 | $2.98M derived: sum of 4 quarters · filed 2024-05-22 |
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.21M derived: sum of 2 quarters · filed 2024-04-01 | $1.29M derived: sum of 3 quarters · filed 2024-04-01 | $1.29M 10-K · filed 2024-04-01 |
| 2022-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $90.80K derived: sum of 2 quarters · filed 2023-11-09 | $90.80K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $80.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | $80.80K 10-Q · filed 2023-08-15 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 |